Providing immunology research for drug safety analysis
Immundnz is a CRO specialised in immunology and in vitro systems for preclinical drug research and development. We are located at the prestigious BioHub campus in Alderley Edge, UK, where we have access to high-end facilities, professionals and a lively network of other life sciences companies. Contact us for more information.
Immundnz offers advanced support in immunology and in vitro research. We have a service portfolio consisting of various techniques and methods. Biological assays, immunoassays, histopathology and mass spectrometry are our core technologies. With these techniques we contribute to innovative drug development, diagnostics and life sciences research.
In vitro systems
We offer cell culture preparation, growth and analysis. We develop 2D cell cultures as well as 3D tissue models such as organoids and 3D microfluidic culture plates. We study the behaviour of drug compounds in in vitro systems.
Any drug molecule has the capacity to cause unwanted tissue damage. The outcome of such damage would be the release of intracellular molecules ‘ to the immune system. An unwanted immune response may be generated from such signals that may progress into a secondary disease including autoimmunity. Immundnz is developing a solution to study this biological process in depth in preclinical phase: COMPIT.
COMPIT, Comprehensive In Vitro Human Immune Response Testing of drug compounds, is our main product. We are currently conducting an EU funded project to research and develop a platform that enables to study the interaction of a drug compound or biomolecule with tissues and the extent of damage that is caused by this interaction to understand drug induced adverse immune response.